According to a recent LinkedIn post from Innovaccer, the company’s Story Health unit has been identified by Fierce Healthcare as one of roughly 150 participants in the Centers for Medicare & Medicaid Services (CMS) ACCESS Model. The post underscores that this CMS initiative is described as shifting reimbursement emphasis from volume of clinical activity to measurable patient outcomes, particularly in chronic disease management.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post suggests that many digital health firms remain oriented around fee-for-service economics, while Innovaccer positions its work with health systems and accountable care organizations as tied to whether patients improve rather than encounter frequency. For investors, participation in an outcomes-focused CMS program could indicate strategic alignment with value-based care trends, potentially enhancing Innovaccer’s relevance to payers and providers as reimbursement models evolve.
The post also notes that Innovaccer’s Medical Director, Ashul Govil, M.D., M.B.A., provided commentary to Fierce Healthcare on what the ACCESS Model is effectively testing. This external visibility in a national trade publication may strengthen Innovaccer’s thought-leadership profile in value-based care and health tech, which could support future commercial opportunities if the model scales or informs broader CMS payment reforms.

